#medtech

2 stories

#business #ai #earnings #eps decline #finance #hedge funds #investor letters #johnson and johnson #mdln #medline #money #nse

JNJ Q3 Earnings Drop Amid Talc Litigation
Johnson & Johnson's Q3 earnings fell as talc litigation costs and medtech slowdown hit.
Seekingalpha · 1m
Medline Shares Drop as MedTech Weakens
Medline stock falls 4.23% in last month amid AI stock pressure and tariff concerns
Yahoo Finance · 1m